Project Grant HT94252510265
Award Date
4/15/25
Completion Date
4/14/29
Dollars Obligated
$3.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The U.S. Department of the Army Medical Command awarded a $577,383 Project Grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a start date of September 1, 2024 and an ultimate completion date of August 31, 2027, will support the hospital's research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS." As...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program provides $617,367.00 to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS". The research, which commenced on Sep 1, 2024 and is scheduled for completion by Aug 31, 2027, aims to explore...
The Department of the Army Medical Command awarded Boston Children's Hospital a $2.788 million Project Grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2021 through June 30, 2025. The grant funds research to develop therapies for Barth Syndrome from the molecular mechanism level. Barth Syndrome is a rare genetic condition that causes cardiac abnormalities and muscle weakness. The Military Medical Research and Development program supports...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $777,927 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will support research into targeting PARP signaling as a novel treatment for urologic complications of spinal cord injury from August 15, 2023 through August 14, 2026. The Military Medical Research and Development program aims to advance biomedical solutions for battlefield...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $796,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2021 through June 2024 to investigate the contribution of rapamycin-insensitive processes to neurological symptoms in tuberous sclerosis complex. The Military Medical Research and Development program aims to advance biomedical...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $1,068,000.00 in funding to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research aimed at "Activating Gasdermin Pores to Induce Pyroptosis and Antitumor Immunity in Ovarian Cancers." The award period is from April 15, 2025 to April 14, 2028. As a premier pediatric medical research...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $796,500 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to investigate clonal evolution in Fanconi anemia. The grant period runs from September 30, 2023 to September 29, 2026. As a non-profit pediatric teaching hospital and research center, Boston Children's Hospital will leverage its expertise in pediatric medicine, genomics, and...
This federal Project Grant award for $711,403.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research project focused on developing a noninvasive neurotrophic factor treatment to repair injured spinal cords. The grant was awarded to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a premier pediatric medical research institution affiliated with Harvard Medical School. The project...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...